MedTech Dive May 9, 2023
Dive Brief:
- The head of the Food and Drug Administration has warned the U.S. needs to be “nimble in the use and regulation of large language models” to avoid being “swept up quickly by something that we hardly understand.”
- FDA Commissioner Robert Califf, speaking Monday at the 2023 Science for Patient Engagement Symposium, said the models are “ushering in the revolution that many of us were hoping for,” but cautioned that the sector will need to be regulated appropriately.
- Califf identified bias as a specific concern, noting that the models and other algorithms “evolve after they are put into practice” and will likely need continuous adjustment throughout the life cycle to remain accurate.
Dive Insight:
Large language models...